Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Genzyme buys Verigen to boost orthopedic offering
Verigen’s proprietary cell therapy product, called MACI, is for cartilage repair and is currently sold in Europe and Australia. MACI will both expand Genzyme’s orthopedic offerings in these
Verigen’s proprietary cell therapy product, called MACI, is for cartilage repair and is currently sold in Europe and Australia. MACI will both expand Genzyme’s orthopedic offerings in these
The international trial is designed to reconfirm the efficacy and beneficial effect of DP-b99 previously observed in stroke patients, as well as to strengthen and extend the safety
Under the terms of the agreement, Auxilium will receive exclusive, worldwide, royalty-bearing rights to develop, manufacture and market eight analgesic compounds using PharmaForm’s proprietary, transmucosal delivery system. The
The researchers reported a direct link between zonulin-mediated increased intestinal permeability and type 1 diabetes (T1D) in the BB/wor rat model of diabetes. The investigators were also able
An independent data safety monitoring board (DSMB) reported that the company’s ongoing phase III registration clinical trial in advanced pancreatic cancer, for its lead anticancer drug Virulizin, can
Fendrix contains the GSK hepatitis B antigen and a novel proprietary GSK adjuvant system, AS04, which includes MPL from Corixa developed to have a higher potency than other
The collaboration will use MethylGene’s isotypic selective, small molecule, histone deacetylase (HDAC) inhibitors and EnVivo’s proprietary in vivo models and discovery platform for neurodegenerative diseases. MethylGene will receive
Under the terms of the acquisition, Barrier made an initial cash payment of $3 million and will make future payments totaling up to an additional $2 million, depending
The barcodes have been included on Lilly’s insulin product outer packaging in the past, but this marks the first time the barcodes are being included on the vial
SB-497115 mimics the activity of thrombopoietin (TPO), a protein factor that promotes growth and production of blood platelets. If the drug ultimately is approved and marketed, Ligand could